U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 60

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr20:44638517
GRCh38:
Chr20:46009878
MMP9R51CMetaphyseal anadysplasia 2Likely pathogenic
(Mar 31, 2021)
criteria provided, single submitter
2.
GRCh37:
Chr20:44640317
GRCh38:
Chr20:46011678
MMP9G310fsMetaphyseal anadysplasia 2Likely pathogenic
(Mar 31, 2021)
criteria provided, single submitter
3.
GRCh37:
Chr20:44639208
GRCh38:
Chr20:46010569
MMP9P153QMetaphyseal anadysplasia 2, not providedUncertain significance
(Jun 20, 2022)
criteria provided, multiple submitters, no conflicts
4.
GRCh37:
Chr20:44641113
GRCh38:
Chr20:46012474
MMP9G408SMetaphyseal anadysplasia 2Uncertain significance
(May 14, 2021)
criteria provided, single submitter
5.
GRCh37:
Chr20:44637645
GRCh38:
Chr20:46009006
MMP9T27Inot provided, Metaphyseal anadysplasia 2Uncertain significance
(Aug 5, 2021)
criteria provided, multiple submitters, no conflicts
6.
GRCh37:
Chr20:44644972
GRCh38:
Chr20:46016333
LOC100128028, MMP9, SLC12A5-AS1V697Mnot provided, Metaphyseal anadysplasia 2Uncertain significance
(Sep 1, 2021)
criteria provided, multiple submitters, no conflicts
7.
GRCh37:
Chr20:44640376
GRCh38:
Chr20:46011737
MMP9C329*Metaphyseal anadysplasia 2Pathogenic
(Jan 2, 2020)
criteria provided, single submitter
8.
GRCh37:
Chr20:44643033
GRCh38:
Chr20:46014394
LOC100128028, MMP9, SLC12A5-AS1V642AMetaphyseal anadysplasia 2Uncertain significance
(Apr 27, 2017)
criteria provided, single submitter
9.
GRCh37:
Chr20:44643014
GRCh38:
Chr20:46014375
LOC100128028, MMP9, SLC12A5-AS1D636HMetaphyseal anadysplasia 2Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
10.
GRCh37:
Chr20:44638625
GRCh38:
Chr20:46009986
MMP9D87NMetaphyseal anadysplasia 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
11.
GRCh37:
Chr20:44638572
GRCh38:
Chr20:46009933
MMP9P69Lnot provided, Metaphyseal anadysplasia 2Uncertain significance
(Aug 16, 2022)
criteria provided, multiple submitters, no conflicts
12.
GRCh37:
Chr20:44638500
GRCh38:
Chr20:46009861
MMP9not provided, Metaphyseal anadysplasia 2Conflicting interpretations of pathogenicity
(Sep 5, 2022)
criteria provided, conflicting interpretations
13.
GRCh37:
Chr20:44642095
GRCh38:
Chr20:46013456
MMP9P511LMetaphyseal anadysplasia 2Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
14.
GRCh37:
Chr20:44641967
GRCh38:
Chr20:46013328
MMP9not provided, Metaphyseal anadysplasia 2Conflicting interpretations of pathogenicity
(Oct 17, 2022)
criteria provided, conflicting interpretations
15.
GRCh37:
Chr20:44641957
GRCh38:
Chr20:46013318
MMP9P465LMetaphyseal anadysplasia 2Uncertain significance
(Apr 27, 2017)
criteria provided, single submitter
16.
GRCh37:
Chr20:44640368
GRCh38:
Chr20:46011729
MMP9G327RMetaphyseal anadysplasia 2Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
17.
GRCh37:
Chr20:44640305
GRCh38:
Chr20:46011666
MMP9G306CMetaphyseal anadysplasia 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
18.
GRCh37:
Chr20:44639952
GRCh38:
Chr20:46011313
MMP9E274KMetaphyseal anadysplasia 2, not providedUncertain significance
(Sep 7, 2022)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr20:44639914
GRCh38:
Chr20:46011275
MMP9N261SMetaphyseal anadysplasia 2, not providedConflicting interpretations of pathogenicity
(Sep 10, 2022)
criteria provided, conflicting interpretations
20.
GRCh37:
Chr20:44644954
GRCh38:
Chr20:46016315
LOC100128028, MMP9, SLC12A5-AS1V691MMetaphyseal anadysplasia 2Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
21.
GRCh37:
Chr20:44639546
GRCh38:
Chr20:46010907
MMP9Metaphyseal anadysplasia 2, not providedConflicting interpretations of pathogenicity
(Sep 7, 2022)
criteria provided, conflicting interpretations
22.
GRCh37:
Chr20:44639201
GRCh38:
Chr20:46010562
MMP9V151MMetaphyseal anadysplasia 2Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
23.
GRCh37:
Chr20:44638710
GRCh38:
Chr20:46010071
MMP9K115RMetaphyseal anadysplasia 2, not providedUncertain significance
(Jul 16, 2022)
criteria provided, multiple submitters, no conflicts
24.
GRCh37:
Chr20:44640229
GRCh38:
Chr20:46011590
MMP9Metaphyseal anadysplasia 2, not providedBenign
(Oct 8, 2022)
criteria provided, multiple submitters, no conflicts
25.
GRCh37:
Chr20:44639599
GRCh38:
Chr20:46010960
MMP9L187FMetaphyseal anadysplasia 2, not providedBenign/Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
26.
GRCh37:
Chr20:44644905
GRCh38:
Chr20:46016266
LOC100128028, MMP9, SLC12A5-AS1not provided, Metaphyseal anadysplasia 2Benign
(Oct 17, 2022)
criteria provided, multiple submitters, no conflicts
27.
GRCh37:
Chr20:44637646
GRCh38:
Chr20:46009007
MMP9not provided, Metaphyseal anadysplasia 2Conflicting interpretations of pathogenicity
(Jul 23, 2022)
criteria provided, conflicting interpretations
28.
GRCh37:
Chr20:44637678
GRCh38:
Chr20:46009039
MMP9N38Snot provided, Metaphyseal anadysplasia 2Benign
(Jan 1, 2023)
criteria provided, multiple submitters, no conflicts
29.
GRCh37:
Chr20:44637635
GRCh38:
Chr20:46008996
MMP9R24Cnot provided, Metaphyseal anadysplasia 2Benign/Likely benign
(Oct 16, 2022)
criteria provided, multiple submitters, no conflicts
30.
GRCh37:
Chr20:44639956-44639961
GRCh38:
Chr20:46011317-46011322
MMP9Metaphyseal anadysplasia 2Uncertain significance
(Nov 28, 2017)
criteria provided, single submitter
31.
GRCh37:
Chr20:44642776
GRCh38:
Chr20:46014137
LOC100128028, MMP9, SLC12A5-AS1W588*not provided, Metaphyseal anadysplasia 2Uncertain significance
(Mar 18, 2022)
criteria provided, multiple submitters, no conflicts
32.
GRCh37:
Chr20:44642364
GRCh38:
Chr20:46013725
LOC100128028, MMP9, SLC12A5-AS1W560*not provided, Metaphyseal anadysplasia 2Uncertain significance
(Sep 6, 2022)
criteria provided, multiple submitters, no conflicts
33.
GRCh37:
Chr20:44641171-44641172
GRCh38:
Chr20:46012532-46012533
MMP9P429fsnot provided, Metaphyseal anadysplasia 2Conflicting interpretations of pathogenicity
(Oct 19, 2022)
criteria provided, conflicting interpretations
34.
GRCh37:
Chr20:44645196
GRCh38:
Chr20:46016557
LOC100128028, MMP9, SLC12A5-AS1Metaphyseal anadysplasia 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
35.
GRCh37:
Chr20:44645153
GRCh38:
Chr20:46016514
LOC100128028, MMP9, SLC12A5-AS1Metaphyseal anadysplasia 2, not providedBenign
(Mar 31, 2019)
criteria provided, multiple submitters, no conflicts
36.
GRCh37:
Chr20:44645010
GRCh38:
Chr20:46016371
LOC100128028, MMP9, SLC12A5-AS1Metaphyseal anadysplasia 2, not providedBenign
(Oct 31, 2022)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr20:44644965
GRCh38:
Chr20:46016326
LOC100128028, MMP9, SLC12A5-AS1Metaphyseal anadysplasia 2, not providedBenign
(Oct 18, 2022)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr20:44644925
GRCh38:
Chr20:46016286
LOC100128028, MMP9, SLC12A5-AS1R681HMetaphyseal anadysplasia 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
39.
GRCh37:
Chr20:44643111
GRCh38:
Chr20:46014472
LOC100128028, MMP9, SLC12A5-AS1R668QMetaphyseal anadysplasia 2, not specified, not provided
Benign
(Oct 18, 2022)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr20:44642903
GRCh38:
Chr20:46014264
LOC100128028, MMP9, SLC12A5-AS1R631SMetaphyseal anadysplasia 2, not providedConflicting interpretations of pathogenicity
(Sep 9, 2022)
criteria provided, conflicting interpretations
41.
GRCh37:
Chr20:44642356
GRCh38:
Chr20:46013717
MMP9, SLC12A5-AS1, LOC100128028Metaphyseal anadysplasia 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
42.
GRCh37:
Chr20:44641883
GRCh38:
Chr20:46013244
MMP9Metaphyseal anadysplasia 2, not providedBenign
(Oct 22, 2022)
criteria provided, multiple submitters, no conflicts
43.
GRCh37:
Chr20:44640966
GRCh38:
Chr20:46012327
MMP9Metaphyseal anadysplasia 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
44.
GRCh37:
Chr20:44640959
GRCh38:
Chr20:46012320
MMP9Metaphyseal anadysplasia 2, not providedBenign
(Nov 4, 2022)
criteria provided, multiple submitters, no conflicts
45.
GRCh37:
Chr20:44640391
GRCh38:
Chr20:46011752
MMP9Metaphyseal anadysplasia 2, not providedBenign
(Oct 30, 2022)
criteria provided, multiple submitters, no conflicts
46.
GRCh37:
Chr20:44640295
GRCh38:
Chr20:46011656
MMP9C302*Metaphyseal anadysplasia 2, not providedConflicting interpretations of pathogenicity
(Jun 4, 2022)
criteria provided, conflicting interpretations
47.
GRCh37:
Chr20:44640267
GRCh38:
Chr20:46011628
MMP9I293NMetaphyseal anadysplasia 2, not providedUncertain significance
(Aug 16, 2022)
criteria provided, multiple submitters, no conflicts
48.
GRCh37:
Chr20:44640225
GRCh38:
Chr20:46011586
MMP9Q279Rnot provided, Metaphyseal anadysplasia 2Benign
(Nov 4, 2022)
criteria provided, multiple submitters, no conflicts
49.
GRCh37:
Chr20:44639848
GRCh38:
Chr20:46011209
MMP9R239Hnot provided, Metaphyseal anadysplasia 2Benign/Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
50.
GRCh37:
Chr20:44639692
GRCh38:
Chr20:46011053
MMP9not specified, not provided, Metaphyseal anadysplasia 2
Benign
(Oct 18, 2022)
criteria provided, multiple submitters, no conflicts
51.
GRCh37:
Chr20:44639214
GRCh38:
Chr20:46010575
MMP9T155Inot provided, Metaphyseal anadysplasia 2Uncertain significance
(Sep 14, 2022)
criteria provided, multiple submitters, no conflicts
52.
GRCh37:
Chr20:44637624
GRCh38:
Chr20:46008985
MMP9A20VMetaphyseal anadysplasia 2, not providedBenign/Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
53.
GRCh37:
Chr20:44637623
GRCh38:
Chr20:46008984
MMP9A20TMetaphyseal anadysplasia 2Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
54.
GRCh37:
Chr20:44637610
GRCh38:
Chr20:46008971
MMP9Metaphyseal anadysplasia 2, not providedBenign/Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
55.
GRCh37:
Chr20:44642833
GRCh38:
Chr20:46014194
MMP9, SLC12A5-AS1, LOC100128028not specified, not provided, Metaphyseal anadysplasia 2
Benign
(Nov 4, 2022)
criteria provided, multiple submitters, no conflicts
56.
GRCh37:
Chr20:44639905
GRCh38:
Chr20:46011266
MMP9T258Inot provided, Metaphyseal anadysplasia 2Conflicting interpretations of pathogenicity
(Oct 26, 2022)
criteria provided, conflicting interpretations
57.
GRCh37:
Chr20:44641977
GRCh38:
Chr20:46013338
MMP9P472Snot provided, Metaphyseal anadysplasia 2Uncertain significance
(Oct 8, 2022)
criteria provided, multiple submitters, no conflicts
58.
GRCh37:
Chr20:44642406
GRCh38:
Chr20:46013767
LOC100128028, MMP9, SLC12A5-AS1R574Pnot specified, not provided, Metaphyseal anadysplasia 2
Benign
(Nov 4, 2022)
criteria provided, multiple submitters, no conflicts
59.
GRCh37:
Chr20:44640275
GRCh38:
Chr20:46011636
MMP9G296Snot provided, Metaphyseal anadysplasia 2Conflicting interpretations of pathogenicity
(Oct 24, 2022)
criteria provided, conflicting interpretations
60.
GRCh37:
Chr20:44637567
GRCh38:
Chr20:46008928
MMP9M1Knot provided, Metaphyseal anadysplasia 2Uncertain significance
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
Format
Items per page
Sort by
Choose Destination